Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: A retrospective cohort study

Digestive and Liver Disease

Volumn 46, Issue 12, 2014, Pages 1116-1120

  Licata, Anna ^a   Maida, Marcello ^a   Cabibi, Daniela ^a   Butera, Giuseppe ^a   Macaluso, Fabio S ^a   Alessi, Nicola ^a   Caruso, Calogero ^a   Craxì, Antonio ^a   Almasio, Piero L ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Autoimmunity; Drug induced liver injury; Human leucocyte antigens; Liver biopsy

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMOXICILLIN PLUS CLAVULANIC ACID; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; CEFTRIAXONE; DIMETHOATE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN; KETOPROFEN; NIMESULIDE; PREDNISONE; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; CLINICAL FEATURE; COHORT ANALYSIS; DRUG INDUCED AUTOIMMUNE HEPATITIS; DRUG INDUCED DISEASE; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; HYPERICUM PERFORATUM; IDIOPATHIC DISEASE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; JAUNDICE; LIVER BIOPSY; LIVER HISTOLOGY; LYMPHOPLASMACYTIC INFILTRATE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; TEA; TOXIC HEPATITIS; TREATMENT DURATION; ADOLESCENT; COMPLICATION; DRUG-INDUCED LIVER INJURY; EVALUATION STUDY; HEPATITIS, AUTOIMMUNE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DRUG-INDUCED LIVER INJURY; FEMALE; FOLLOW-UP STUDIES; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84930934316     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2014.08.040     Document Type: Article

References (25)

1. Suzuki A, Brunt EM, Kleiner DE, et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology 2011;54:931-9.
2. Navarro VJ, Senior JR. Drug-related hepatotoxicity. New England Journal of Medicine 2006;354:731-9.
3. Ostapowicz G, Fontana RJ, Schiodt FV, et al., U.S. Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Annals of Internal Medicine 2002;137:947-54.
4. Wei G, Bergquist A, Broomé U, et al. Acute liver failure in Sweden: etiology and outcome. Journal of Internal Medicine 2007;262:393-401.
5. Björnsson E, Talwalkar J, Treeprasertsuk S, et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology 2010;51:2040-8.
6. Germano V, Picchianti Diamanti A, Baccano G, et al. Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis. Annals of the Rheumatic Diseases 2005;64:1519-20.
7. Wolters LM, Van Buuren HR. Rosuvastatin-associated hepatitis with autoimmune features. European Journal of Gastroenterology and Hepatology 2005;17:589-90.
8. Kamiyama T, Nouchi T, Kojima S, et al. Autoimmune hepatitis triggered by administration of an herbal medicine. American Journal of Gastroenterology 1997;92:703-4.
9. Licata A, Macaluso FS, Craxì A. Herbal hepatotoxicity: a hidden epidemic. Internal and Emergency Medicine 2013;8:13-22.
10. Czaja AJ. Drug-induced autoimmune-like hepatitis. Digestive Diseases and Sciences 2011;56:958-76.
11. Fontana RJ, Seeff LB, Andrade RJ, et al. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology 2010;52:730-42.
12. Aithal Gp PB, Watkins RJ, Andrade D, et al. Case definition and phenotype standardization in drug-induced liver injury. Clinical Pharmacology and Therapeutics 2011;89:806-15.
13. Weiler Normann C, Schramm C. Drug-induced liver injury and its relationship between to autoimmune hepatitis. Journal of Hepatology 2011;55:747-9.
14. Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48:169-76.
15. Macaluso FS, Maida M, Cammà C, et al. Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C. Journal of Hepatology 2014;61:523-9.
16. Di Marco V, Calvaruso V, Iacò A, et al. Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis. Gut 2011;60:1023.
17. Lucena MI, Kaplowitz N, Hallal H, et al. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish registry: the dilemma of the relationship with autoimmune hepatitis. Journal of Hepatology 2011;55:820-7.
18. Qiu DK, Ma X. Relationship between human leukocyte antigen-DRB1 and autoimmune hepatitis type I in Chinese patients. Journal of Gastroenterology and Hepatology 2003;18:63-7.
19. Goldberg AC, Bittencourt PL, Bougin P, et al. Analysis of HLA haplotypesin autoimmune hepatitis type 1: identifying the major susceptibility locus.Human Immunology 2001;62:165-9.
20. Oliveira LC, Porta G, Marin ML, et al. Autoimmune hepatitis, HLA and extended haplotypes. Autoimmunity Reviews 2011;10:189-93.
21. Lucena MI, Molokhia M, Shen Y, et al. Susceptibility toamoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology 2011;141:338-47.
22. Donaldson PT, Daly AK, Henderson J, et al. Human leucocyte antigen class IIgenotype in susceptibility and resistance to co-amoxiclav-induced liver injury.Journal of Hepatology 2010;53:1049-53.
23. Daly AK, Donaldson PT, Bhatnagar P, et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nature Genetics 2009;41:816-9.
24. Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoim-mune hepatitis. Hepatology 2010;51:2193-213.
25. vanGerven NM, Verwer BJ, Witte BI, et al. Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission. Journal of Hepatology 2013;58:141-7.